Medtronic's PulseSelect pulsed field ablation (PFA) system has earned a CE mark, the company announced on 20 November.
PulseSelect is indicated to treat atrial fibrillation with pulmonary vein isolation ablation. One-year results from the PULSED AF trial of the PulseSelect PFA system showed a 0.7% adverse event rate in 300 patients with atrial fibrillation